genome

Special An Emirati man gets vaccinated against the COVID-19 coronavirus at Al-Barsha Health Center on Dec. 24, 2020. (AFP/File Photo)

Pandemic puts a Gulf AI company on the cutting edge of genome research

  • Genetic analysis to help scientists better understand origins of COVID-19, identify variants and improve testing
  • If successful, Abu Dhabi-based G42 Healthcare’s Hayat-Vax will make the UAE the first Arab country to produce a COVID-19 vaccine
By Rebecca Anne Proctor ·